Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03646825 · ClinicalTrials.gov registry record
Effect of Natural Antioxidant Supplement on Sperm DNA Fragmentation
A clinical trial, sponsored by Colorado Center for Reproductive Medicine.
- Terminated
- Registry status
- 54
- Enrollment target
NCT03646825: Clinical Trial study, sponsored by Colorado Center for Reproductive Medicine.
NCT03646825 is a clinical trial that was terminated before completion, run by Colorado Center for Reproductive Medicine. The registered enrollment target is 54 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03646825 was terminated before completion, sponsored by Colorado Center for Reproductive Medicine.
- TERMINATED
- Registry status
- 54 participants
- Enrollment target
Study Summary
Observational study to see the effect of use of natural Antioxidant supplement on sperm DNA fragmentation. Subjects will take the natural antioxidant for 3 months prior to repeat testing.
Primary Outcome
Direct comparison of sperm DNA fragmentation pre and post natural antioxidant exposure
Interventions
- DIETARY_SUPPLEMENT Natural Antioxidant supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2022-10-01 |
Why NCT03646825 stopped before completion
NCT03646825 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 54 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Natural Antioxidant supplement is the first listed.
NCT03646825 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03646825 about?
NCT03646825 is a clinical study titled "Effect of Natural Antioxidant Supplement on Sperm DNA Fragmentation". Observational study to see the effect of use of natural Antioxidant supplement on sperm DNA fragmentation. Subjects will take the natural antioxidant for 3 months prior to repeat testing.
What is the current status of trial NCT03646825?
This trial is currently terminated. The enrollment target is 54 participants. The study started on 2018-08-01. Estimated completion is 2022-10-01.
What interventions are being tested in trial NCT03646825?
The interventions under investigation include: Natural Antioxidant supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03646825?
This trial is sponsored by Colorado Center for Reproductive Medicine, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI